Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Vexol
Active Ingredient: Rimexolone 10mg/mL
Dosage Form: Eye drops, suspension
New Zealand Sponsor: Alcon New Zealand Limited
Manufacturers: SA Alcon Couvreur NV, Puurs, Belgium
Alcon Cusi SA, El Masnou, Barcelona, Spain
Product: Volibris
Active Ingredient: Ambrisentan 10mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Patheon Inc, Toronto Region Operations, Mississauga, Ontario, Canada
Product: Volibris
Active Ingredient: Ambrisentan 5mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Patheon Inc, Toronto Region Operations, Mississauga, Ontario, Canada
Product: Xarelto
Active Ingredient: Rivaroxaban 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Bayer Healthcare AG, Bayerwerk, Germany
Dated this 11th day of August 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).